Virtus ETF Advisers’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,536
| Closed | -$340K | – | 459 |
|
|
2024
Q4 | $340K | Buy |
11,536
+3,238
| +39% | +$95.5K | 0.14% | 216 |
|
|
2024
Q3 | $258K | Hold |
8,298
| – | – | 0.12% | 239 |
|
|
2024
Q2 | $281K | Buy |
8,298
+2,336
| +39% | +$79.2K | 0.14% | 235 |
|
|
2024
Q1 | $388K | Buy |
5,962
+858
| +17% | +$55.8K | 0.21% | 198 |
|
|
2023
Q4 | $349K | Sell |
5,104
-161
| -3% | -$11K | 0.22% | 188 |
|
|
2023
Q3 | $273K | Sell |
5,265
-684
| -11% | -$35.5K | 0.17% | 211 |
|
|
2023
Q2 | $357K | Buy |
5,949
+722
| +14% | +$43.3K | 0.21% | 149 |
|
|
2023
Q1 | $258K | Buy |
5,227
+96
| +2% | +$4.75K | 0.14% | 276 |
|
|
2022
Q4 | $293K | Sell |
5,131
-3,507
| -41% | -$200K | 0.15% | 278 |
|
|
2022
Q3 | $405K | Buy |
8,638
+125
| +1% | +$5.86K | 0.16% | 228 |
|
|
2022
Q2 | $318K | Buy |
8,513
+3,297
| +63% | +$123K | 0.12% | 262 |
|
|
2022
Q1 | $156K | Sell |
5,216
-307
| -6% | -$9.18K | 0.07% | 222 |
|
|
2021
Q4 | $189K | Buy |
5,523
+164
| +3% | +$5.61K | 0.07% | 231 |
|
|
2021
Q3 | $199K | Sell |
5,359
-275
| -5% | -$10.2K | 0.09% | 271 |
|
|
2021
Q2 | $220K | Buy |
+5,634
| New | +$220K | 0.09% | 274 |
|